$CRH

CRH to Buy Arcosa, Shares Skid

CRH said it will buy 100% of Arcosa in an all-cash deal for $150 per share, subject to Arcosa shareholder and regulatory approvals. The offer implies a 25% premium to Arcosa’s June 18 60-day VWAP. CRH values Arcosa at about $8.5B enterprise value (11.5x 2026E adj. EBITDA) and expects $175M annual synergies by year three.

Original reporting
Published Jun 25, 2026, 8:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 8:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CRH to Buy Arcosa, Shares Skid — source image
Decision brief

The 30-second read

$CRHBullishHigh
01

Why it matters

The disclosed all-cash $150/share offer, 25% premium to 60-day VWAP, $8.5B EV valuation, and $175M run-rate synergies by year three create a clear, tradable takeover setup for both bidder and target.

02

Market read

This is a fresh M&A bid with explicit pricing and premium, directly impacting target valuation and bidder risk/reward.

03

What to watch

The article omits financing details, integration risks, and specific regulatory timeline—key drivers of deal probability and spread behavior.

Relevance 9/10Novelty 9/10Timing: deal announcement today; immediate takeover-spread positioning

Background

CRH is a building materials provider; Arcosa supplies infrastructure-related materials and engineered structures, described as complementary to CRH’s portfolio.

Company-level read

Ticker impact

$CRHBullishMedium confidence
Context

CRH signed an all-cash agreement to acquire 100% of Arcosa, valuing the deal and setting approval/regulatory milestones.

Expected impact

Likely supportive for CRH on deal premium/strategic fit, but with volatility around regulatory/approval odds and financing assumptions.

Evidence & confidence

The article discloses deal terms ($150/share, 25% premium, $8.5B EV, 11.5x EBITDA, $175M synergies) but not financing or regulatory timeline details.

$ACABullishHigh confidence
Context

Arcosa is the target in CRH’s proposed $150/share all-cash acquisition, implying a 25% premium and requiring approvals.

Expected impact

Arcosa likely trades toward the offer price with elevated spread volatility until approvals/regulatory outcomes are clearer.

Evidence & confidence

The article provides the offer price, premium reference (to 60-day VWAP), and deal valuation, which are the core drivers of target pricing.

Market effects

Signals continued consolidation in U.S. construction materials and infrastructure-related products, potentially affecting comps and M&A expectations.

Increases exposure to fast-growing U.S. MSAs via Arcosa’s aggregates and infrastructure materials footprint.

Strengthens CRH’s connected portfolio strategy and could shift competitive dynamics in global aggregates and engineered structures.

Counterpoint

Deal spreads can widen if regulatory scrutiny or financing/antitrust concerns emerge, even when the offer premium is attractive.

Key entities

  • CRH

    Signed an agreement to acquire 100% of Arcosa in an all-cash transaction.

  • Arcosa, Inc.

    Agreed to be acquired by CRH at $150 per share, subject to approvals.

Related articles

$CRHMed

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.

$ACAMed

Arcosa, Inc. (ACA): Results of Operations and Financial Condition

Arcosa, Inc. (ACA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991earningsrelease63020.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Arcosa, Inc. Announces Second Quarter 2026 Results DALLAS, Texas - ARCOSA, Inc. - August 5, 2026: Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provid

$CRHMedAI 8/10

CRH reports stronger 2Q26 earnings and reaffirms outlook

CRH reported 2Q26 revenues of US$10.8bn, up 6% year over year, and net income up 13% to US$1.5bn. Adjusted EBITDA rose 7% to US$2.6bn, with margins improving. CRH completed three non-core divestments and invested US$1.4bn in 17 acquisitions YTD, and agreed to buy Arcosa for US$8.5bn. It reaffirmed 2026 guidance: net income US$3.9-4.1bn, adjusted EBITDA US$8.1-8.5bn, EPS US$5.60-6.05.

$CRHMedAI 8/10

CRH's second quarter revenues up on pricing and demand

CRH reported Q2 2026 revenues up 6% to $10.8 billion, net income up 13% to $1.5 billion, adjusted EBITDA up 7% to $2.6 billion, and diluted EPS up 14% to $2.21, citing pricing momentum, demand, and acquisitions. The company reaffirmed full-year guidance and completed $1.1 billion of acquisitions and $1.7 billion of net divestiture proceeds.

$CRHHigh

CRH PUBLIC LTD CO (CRH): Results of Operations and Financial Condition

CRH PUBLIC LTD CO (CRH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2resultsannouncement2026.htm EX-99.1 Document Exhibit 99.1 CRH Reports Second Quarter 2026 Results • Strong quarter driven by good commercial management, favorable underlying demand and contributions from acquisitions • Increases in revenues, profits and margins reflec